Global Analysis of Ebola Disease
Global Analysis of Ebola Disease
Expenditure on Prevention and Containment to Soar towards $5.9 Billion by End of 2016
18-Nov-2014
North America
Market Research
$2,450.00
Special Price $1,837.50 save 25 %
This market insight provides a first-of-its-kind analysis of market sizing and revenue forecasts through 2016 for the prevalent Ebola virus. The number of people infected nears 10,000 globally, and the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have deemed this the worst outbreak due to the death toll nearing 5,000. The Ebola market is segmented by diagnostics and pharmaceuticals, and the diagnostics market includes both molecular methods and immunodiagnostics tests, of which a 2-year potential-revenue forecast is provided. Molecular methods will see wide adoption for the specificity, sensitivity, and rapidity of the tests. Competitive landscape and companies to watch chapters are provided.
Key Findings
What is Ebola?
Timeline of Key Events
Scope and Segmentation
Key Questions This Study Will Answer
CEO’s Perspective
Spread of Ebola
Methodology, Assumptions, and Definitions
Methodology, Assumptions, and Definitions (continued)
Methodology, Assumptions, and Definitions (continued)
Methodology, Assumptions, and Definitions (continued)
Projected Ebola Prevalence (Global)
Ebola Market for Molecular Tests (Global)
Ebola Market for Immunodiagnostic Tests (Global)
Global Expenditure Forecast by Mild Cases of Ebola
Global Expenditure Forecast by Severe Cases of Ebola
Global Expenditure Forecast Comparing Mild and Severe Ebola Cases
Competitive Landscape for Pipeline Vaccines and Drugs
Competitive Landscape for Diagnostic Products
Ebola Diagnostics
Ebola Drugs and Vaccines
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Deliverable Type | Market Research |
---|---|
No Index | Yes |
Podcast | No |
Author | Aish Vivekanadan |
WIP Number | NED3-01-00-00-00 |
Is Prebook | No |